Pascal Touchon - 16 May 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
16 May 2023
Net transactions value
-$60,633
Form type
4
Filing time
18 May 2023, 20:17:21 UTC
Previous filing
06 Mar 2023
Next filing
29 Jun 2023
SEC
View on sec.gov

Quoteable Key Fact

"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 18 May 2023."

Quick Takeaways

  • This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 18 May 2023, 20:17.

What Changed

  • Previous filing in this sequence was filed on 06 Mar 2023.
  • Current net transaction value: -$60,633.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $60,633 -29,766 -4% $2.04 720,962 16 May 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 and May 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.